ライフサイエンスコーパス: hyporeactivity

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 t biomarker of tolerance than donor-specific hyporeactivity.

2 in the development of donor antigen-specific hyporeactivity.

3 and donor-specific mixed lymphocyte reaction hyporeactivity.

4 eaction demonstrated in vitro donor-specific hyporeactivity.

5 /W, 8-hourly) corrects the in vitro vascular hyporeactivity.

6 5), suggesting impaired vasoconstriction and hyporeactivity.

7 As a result, both hyporeactivity and hypotension are reversed, generation

8 n, CMV infection, OB, donor antigen-specific hyporeactivity, and pulmonary function.

9 Similar immune hyporeactivity, associated with an elevated risk of succ

10 DSBM may, thus, induce graft hyporeactivity by impairing intragraft immune activation

11 plant correlated with donor antigen-specific hyporeactivity (i.e., decreased proliferative response t

12 aride-induced hypotension and cardiovascular hyporeactivity in animal models of septic shock and in m

13 tal-hypertensive rats show in vitro vascular hyporeactivity in large part mediated by the endothelium

14 reotide treatment prevents in vitro vascular hyporeactivity in prehepatic portal-hypertensive rats, a

15 MEG also reduced the degree of vascular hyporeactivity in rat thoracic aortic rings exposed to p

16 arly phase of hypotension and cardiovascular hyporeactivity in sepsis, and the cellular sources of in

17 ith functional endothelium but, in contrast, hyporeactivity in vessels without functional endothelium

18 toxicity but does contribute to the vascular hyporeactivity induced by endotoxin in vitro and in vivo

19 tration actually confers donor-specific (DS) hyporeactivity is unknown.

20 Vascular hyporeactivity of ex vivo aortas was ameliorated.

21 The SMA hyporeactivity of PVL-20G and RAL rats was corrected by

22 de also reduced PARS activation and vascular hyporeactivity of rat thoracic aortas exposed to ONOO- (

23 sease frequently presents with an underlying hyporeactivity or hyperreactivity of the HPA stress axis

24 arly phase of hypotension and cardiovascular hyporeactivity seen in septic shock.

25 hese animals did not express iNOS or display hyporeactivity to ACh or SPER-NO.

26 and associated with an in vivo and in vitro hyporeactivity to alloantigens.

27 40401 protects against hypotension, vascular hyporeactivity to catecholamines, and mortality associat

28 deactivation would appear to account for the hyporeactivity to exogenous catecholamines observed in s

29 of knockout mice demonstrated a generalized hyporeactivity to methacholine-induced airflow changes (

30 asculature of PVL-20G and RAL animals showed hyporeactivity to methoxamine (P < 0.01).

31 otension, which was associated with a marked hyporeactivity to norepinephrine in ex vivo thoracic aor

32 ther treatment with M40401 could reverse the hyporeactivity to norepinephrine typifying early septic

33 implicated in the vasodilation and vascular hyporeactivity underlying septic shock.

34 intragraft CD8+ cells, and (3) DSBM induces hyporeactivity up until the day of the allograft placeme

35 e two recipient populations to determine why hyporeactivity was lower in the CCTT group than at our c

36 A lower rate of donor antigen-specific hyporeactivity was seen in the CCTT recipients (6 of 79=

37 isease protection was attributable to T cell hyporeactivity, which was secondary to changes in thymic

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。